SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Tesla, Inc. engages in the design, development, manufacture, and sale of electric vehicles and energy generation and storage systems. It operates through the Automotive and Energy Generation and Storage segments. The Automotive segment includes the design, development, manufacture, sale, and lease of electric vehicles as well as sales of automotive regulatory credits. The Energy Generation and Storage segment is involved in the design, manufacture, installation, sale, and lease of solar energy generation, energy storage products, and related services and sales of solar energy systems incentives. The company was founded by Jeffrey B. Straubel, Elon Reeve Musk, Martin Eberhard, and Marc Tarpenning on July 1, 2003 and is headquartered in Austin, TX.

Tesla Inc

Tesla is trending as community members discuss Elon Musk's recent purchase of $1 billion in TSLA shares, which many see as a strong signal of confidence. The move has sparked discussions about a potential short squeeze and the stock's future trajectory, with some anticipating a continued rally while others remain skeptical of the company's fundamentals.

Helius Medical Technologies, Inc. is a neurotech company in the medical device industry that focuses on neurological wellness. The firm develops, licenses and acquires non-invasive platform technologies that amplify the brain’s ability to heal itself and reduce symptoms of neurological disease or trauma. It engages in the development of the investigational portable neuromodulation stimulator, that delivers neurostimulation via the tongue which has been shown in clinical studies to enhance the effectiveness of physical exercises in people with neurological symptoms from disease or trauma such as mild-to-moderate traumatic brain injury. The company was founded on March 13, 2014 and is headquartered in Newtown, PA.

Helius Medical Technologies Inc - Ordinary Shares - Class A

Helius Medical Technologies Inc

HSDT is trending due to speculation surrounding a potential SOL treasury announcement and recent positive outcomes from their stroke study, leading to discussions about a possible short squeeze. Community members are actively debating the stock's potential for a significant run, drawing comparisons to other companies that have launched crypto treasury initiatives. However, concerns remain regarding the company's history of reverse splits and dilution.

CoreWeave, Inc. engages in the powers of the creation and delivery of the intelligence that drives innovation. It offers a solution used by organizations of all sizes that require sophisticated AI computing, from the largest of enterprises to small, well-funded start-ups. The company was founded by Michael Intrator, Brian Venturo, and Brannin McBee on September 21, 2017 and is headquartered in Livingston, NJ.

CoreWeave Inc. - Ordinary Shares - Class A

CoreWeave Inc

CoreWeave is trending due to a mix of bullish news, including a new $6.3B cloud capacity deal with Nvidia, and bearish sentiment from Kerrisdale Capital announcing a short position with a 90% downside target. The community is debating the impact of the Nvidia deal, potential UK data center investments, and whether the recent price action is setting up for a short squeeze or a further pullback. Discussions also revolve around insider selling and its effect on investor confidence.

Asset Entities, Inc. engages in providing social media marketing and content delivery services. It offers its services to Discord, TikTok, and other social media platforms. It also designs, develops and manages servers for communities on Discord. The company was founded by Arshia Sarkhani, Jackson Fairbanks, Arman Sarkhani and Kyle Fairbanks on August 1, 2020 and is headquartered in Dallas, TX.

Strive Inc. - Ordinary Shares - Class A

Asset Entities Inc.

Asset Entities Inc. ($ASST) is trending due to high volatility following its merger, with discussions focused on trading halts and the potential for a short squeeze. The community is debating the impact of a new share repurchase program and potential Bitcoin purchases, while also noting the CUSIP change affecting trading on some platforms. Overall, traders are closely watching the stock's price action and the potential for significant swings.

Rumble, Inc. engages in operating an online neutral video platform. It operates through the following geographical segments: United States, Canada, and Other. The company was founded in October 2013 by Chris Pavlovski and is headquartered in Longboat Key, FL.

Rumble Inc - Ordinary Shares - Class A

Rumble Inc

Rumble Inc. is trending amidst discussions around its high short interest, potential for a short squeeze, and the upcoming launch of its Rumble Wallet. Some see the stock as a play on a shift in media and cloud services towards platforms valuing free speech, further fueled by the perceived support from prominent figures. Additionally, the possible acquisition of Northern Data and its impact on Rumble's cloud capacity is a hot topic.

IonQ, Inc. develops and manufactures quantum computers. The firm specializes in quantum computing and quantum information processing. The company was founded by Christopher Monroe and Jung Sang Kim in 2015 and is headquartered in College Park, MD.

IonQ Inc

IONQ is trending due to renewed investor optimism surrounding quantum computing, fueled by recent regulatory approval for its acquisition of Oxford Ionics and the launch of IonQ Federal. Community discussions revolve around the company's growth potential, upcoming Analyst Day, and comparisons to other quantum computing firms. Some traders are pointing towards technical breakouts, while others are wary of the high valuation.

Archer Aviation, Inc. engages in the development of electric vertical take-off and landing (eVTOL) aircraft. The company was founded by Brett Adcock and Adam Goldstein on October 16, 2018, and is headquartered in San Jose, CA.

Archer Aviation Inc - Ordinary Shares - Class A

Archer Aviation Inc

Archer Aviation is trending as the community discusses potential catalysts like FAA certification and new partnerships, while also debating whether recent price action indicates a buying opportunity or further downside. Some speculate about government contracts and compare ACHR to competitors like $JOBY in the eVTOL space. Concerns about a short report and the CEO's communication are also prevalent.

NanoVibronix, Inc. engages in the development of noninvasive biological response-activating devices. The firm's products include UroShield and PainShield. It operates through the following geographical segments: United States, Europe, Australia, India, Israel, and Other. The company was founded by Harold Jacob and Jona Zumeris in September 2003 and is headquartered in Tyler, TX.

NanoVibronix Inc

NanoVibronix is trending as traders discuss its low float and potential short squeeze, following news of a granted U.S. patent for pediatric feeding tube guidance. Community members are actively monitoring price levels and volume, with some anticipating a significant upward move, while others remain cautious due to the stock's history of reverse splits. Discussions also involve potential price targets and the impact of the new patent on the company's commercialization path.

Applied Digital Corp. is a technology company, which engages in the provision of development and operation of data centers which provide computing power. It operates through the Data Center Hosting Business and HPC Hosting Business segments. The Data Center Hosting Business segment provides energized infrastructure services to crypto mining customers. The HPC Hosting Business segment focuses on the designing, constructing, and operating data centers tailored to support high power density applications like HPC and AI. The company was founded by Wesley Carl Cummins and Jason Zhang in May 2001 and is headquartered in Dallas, TX.

Applied Digital Corporation

Applied Digital ($APLD) is trending as investors celebrate news that a tenant, CoreWeave, signed a large order form with NVIDIA, signaling strong demand for data center capacity and AI infrastructure. The community is optimistic about APLD's prospects in the AI sector and anticipates further announcements regarding new partnerships and data center developments. Bullish sentiment is fueled by the potential for a short squeeze and the company's strategic positioning in the growing AI market.

Monte Rosa Therapeutics, Inc. operates as a biotechnology company focused on developing precision medicines. The company was founded on November 21, 2019 and is headquartered in Boston, MA.

Monte Rosa Therapeutics Inc

Monte Rosa Therapeutics is trending following a licensing deal with Novartis to develop molecular glue degraders for immune-mediated diseases, potentially worth billions. The community is speculating about a possible bidding war for the company between Novartis and Roche. Discussions also revolve around the company's cash position and potential price target upgrades.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biogen Inc. (BIIB) Surpasses Q2 Earnings and Revenue Estimates

Biogen (BIIB) delivered earnings and revenue surprises of +39.19% and +13.89%, respectively, for the quarter ended June 2025. Do the numbers hold clues to what lies ahead for the stock?

Caribou Biosciences (CRBU) Upgraded to Buy: Here's What You Should Know

Caribou Biosciences, Inc. (CRBU) Reports Q1 Loss, Misses Revenue Estimates

CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit

CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities Fraud Lawsuit CRBU Deadline: CRBU Investors Have Opportunity to Lead Caribou Biosciences, Inc. Securities...

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU

Shareholders of Caribou Biosciences, Inc. Should Contact The Gross Law Firm Before February 24, 2025 to Discuss Your Rights - CRBU Shareholders of Caribou Biosciences, Inc. Should Contact The Gross...

February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBU

February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBU February 24, 2025 Deadline: Contact Levi & Korsinsky to Join Class Action Suit Against CRBU PR Newswire NEW...

Faruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU

Faruqi & Faruqi Reminds Caribou Biosciences Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU Faruqi & Faruqi Reminds Caribou Biosciences...

Caribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU

Caribou Biosciences, Inc. Class Action: The Gross Law Firm Reminds Caribou Biosciences, Inc. Investors of the Pending Class Action Lawsuit with a Lead Plaintiff Deadline of February 24, 2025 - CRBU...

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBU

INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Caribou Biosciences, Inc. of Class Action Lawsuit and Upcoming Deadlines - CRBU INVESTOR ALERT: Pomerantz Law...

Caribou Biosciences, Inc. engages in the development of an internal pipeline of off-the-shelf CAR-T and CAR-NK cell therapies. Its tools and technologies provide transformative capabilities to basic and applied biological research, therapeutic development, agricultural biotechnology, and industrial biotechnology. The company was founded by Jennifer A. Doudna, Rachel E. Haurwitz, Martin Jinek and James Berger on October 28, 2011 and is headquartered in Berkeley, CA.

Current Price	$1.82
Prev Close	$1.80
Open	$1.84
Dividend Yield	0.00%
50-Day Moving Average	$1.90
Beta	1.66
Avg. Volume	989,146.62
PE Ratio	-1.01

52-Week High	$3.00
52-Week Low	$0.66
Market Capitalization	$167.62M
EPS (Annual)	-$1.65
Price to Book	1.01
Revenue Per Employee	$67,986.40
Enterprise Value/EBITDA	N/A

CRBU
Caribou Biosciences Inc

Feed

News

Sentiment

Earnings

Fundamentals

Info

Latest CRBU News

CRBU Caribou Biosciences Inc